$AGX
ARGAN INC

2022 Q2 Form 10-Q Financial Statement

#000155837022009830 Filed on June 08, 2022

View on sec.gov

Income Statement

Concept 2022 Q2 2022 Q1 2021 Q2
Revenue $100.3M $125.6M $126.3M
YoY Change -20.63% 7.14% 110.05%
Cost Of Revenue $80.54M $103.3M $102.6M
YoY Change -21.52% 8.55% 82.81%
Gross Profit $19.74M $22.23M $23.71M
YoY Change -16.77% 0.59% 491.52%
Gross Profit Margin 19.68% 17.7% 18.77%
Selling, General & Admin $10.58M $15.51M $9.892M
YoY Change 6.9% 52.04% -4.37%
% of Gross Profit 53.58% 69.76% 41.71%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $809.0K $997.0K $882.0K
YoY Change -8.28% -9.36% -5.87%
% of Gross Profit 4.1% 4.48% 3.72%
Operating Expenses $10.58M $15.51M $9.892M
YoY Change 6.9% 52.04% -4.37%
Operating Profit $9.163M $6.723M $13.82M
YoY Change -33.71% -43.5% -318.18%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net $595.0K $983.0K $712.0K
YoY Change -16.43% 883.0% -34.56%
Pretax Income $9.758M -$195.0K $14.53M
YoY Change -32.86% -101.63% -377.0%
Income Tax $2.273M $128.0K $3.768M
% Of Pretax Income 23.29% 25.93%
Net Earnings $7.485M $2.215M $10.77M
YoY Change -30.48% -76.93% -1511.01%
Net Earnings / Revenue 7.46% 1.76% 8.52%
Basic Earnings Per Share $0.50 $0.68
Diluted Earnings Per Share $0.50 $141.0K $0.67
COMMON SHARES
Basic Shares Outstanding 14.91M 15.73M
Diluted Shares Outstanding 14.99M 15.96M

Balance Sheet

Concept 2022 Q2 2022 Q1 2021 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $367.5M $440.5M $466.8M
YoY Change -21.27% -3.55% 28.4%
Cash & Equivalents $192.3M $350.5M $396.7M
Short-Term Investments $175.2M $90.03M $70.08M
Other Short-Term Assets $37.18M $34.90M $33.74M
YoY Change 10.18% 2.22% -8.55%
Inventory
Prepaid Expenses $2.954M
Receivables $36.05M $26.98M $32.38M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $447.6M $507.3M $559.0M
YoY Change -19.93% -7.13% 22.67%
LONG-TERM ASSETS
Property, Plant & Equipment $9.936M $10.46M $19.94M
YoY Change -50.18% -48.63% -18.6%
Goodwill $28.03M $28.03M $27.94M
YoY Change 0.32% 0.32% 0.0%
Intangibles $3.175M $3.322M $3.869M
YoY Change -17.94% -18.92%
Long-Term Investments $800.0K $200.0K
YoY Change
Other Assets $457.0K $0.00
YoY Change 128.5%
Total Long-Term Assets $45.22M $46.30M $58.94M
YoY Change -23.28% -17.92% 2.99%
TOTAL ASSETS
Total Short-Term Assets $447.6M $507.3M $559.0M
Total Long-Term Assets $45.22M $46.30M $58.94M
Total Assets $492.8M $553.6M $618.0M
YoY Change -20.25% -8.14% 20.47%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $39.94M $41.82M $41.47M
YoY Change -3.68% -21.53% 20.9%
Accrued Expenses $39.37M $53.32M $42.05M
YoY Change -6.39% 5.05% 45.0%
Deferred Revenue $107.0M $127.9M $199.5M
YoY Change -46.4% -25.66%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $186.3M $223.0M $283.1M
YoY Change -34.19% -19.22% 63.52%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $4.523M $4.963M $3.741M
YoY Change 20.9% 20.02% 43.88%
Total Long-Term Liabilities $4.523M $4.963M $3.741M
YoY Change 20.9% 20.02% 43.88%
TOTAL LIABILITIES
Total Short-Term Liabilities $186.3M $223.0M $283.1M
Total Long-Term Liabilities $4.523M $4.963M $3.741M
Total Liabilities $190.8M $228.0M $287.2M
YoY Change -33.56% -18.64% 61.51%
SHAREHOLDERS EQUITY
Retained Earnings $192.5M $188.7M $172.9M
YoY Change 11.29% 13.59%
Common Stock $161.5M $160.6M $157.3M
YoY Change 2.67% 3.14%
Preferred Stock
YoY Change
Treasury Stock (at cost) $47.48M $20.41M
YoY Change 61733.33%
Treasury Stock Shares $1.242M $531.0K
Shareholders Equity $302.8M $326.4M $329.1M
YoY Change
Total Liabilities & Shareholders Equity $492.8M $553.6M $618.0M
YoY Change -20.25% -8.14% 20.46%

Cashflow Statement

Concept 2022 Q2 2022 Q1 2021 Q2
OPERATING ACTIVITIES
Net Income $7.485M $2.215M $10.77M
YoY Change -30.48% -76.93% -1511.01%
Depreciation, Depletion And Amortization $809.0K $997.0K $882.0K
YoY Change -8.28% -9.36% -5.87%
Cash From Operating Activities -$39.73M -$13.28M $17.35M
YoY Change -329.04% -141.38% -56.84%
INVESTING ACTIVITIES
Capital Expenditures -$238.0K -$299.0K $844.0K
YoY Change -128.2% -0.33% 23.39%
Acquisitions
YoY Change
Other Investing Activities -$85.00M -$1.531M $16.48M
YoY Change -615.78% -72.53%
Cash From Investing Activities -$85.24M -$1.830M $15.64M
YoY Change -645.14% 510.0% -73.64%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $27.08M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -30.72M -24.17M -2.919M
YoY Change 952.52% 25.9% -21.81%
NET CHANGE
Cash From Operating Activities -39.73M -13.28M 17.35M
Cash From Investing Activities -85.24M -1.830M 15.64M
Cash From Financing Activities -30.72M -24.17M -2.919M
Net Change In Cash -158.2M -39.29M 30.00M
YoY Change -627.32% -411.8% -68.6%
FREE CASH FLOW
Cash From Operating Activities -$39.73M -$13.28M $17.35M
Capital Expenditures -$238.0K -$299.0K $844.0K
Free Cash Flow -$39.49M -$12.98M $16.50M
YoY Change -339.32% -140.08% -58.23%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q2 us-gaap Lessee Operating Lease Existence Of Option To Terminate
LesseeOperatingLeaseExistenceOfOptionToTerminate
true
CY2022Q2 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.25
CY2022Q2 dei Document Type
DocumentType
10-Q
CY2022Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q2 us-gaap Lessee Operating Lease Existence Of Option To Extend
LesseeOperatingLeaseExistenceOfOptionToExtend
true
CY2022Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q2 us-gaap Preferred Stock Value
PreferredStockValue
CY2022Q1 us-gaap Preferred Stock Value
PreferredStockValue
CY2022Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
3175000
CY2022Q2 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2021-01-31#AccruedLiabilitiesCurrent
CY2022Q2 us-gaap Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List
OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesNoncurrent
CY2022Q2 dei Entity Central Index Key
EntityCentralIndexKey
0000100591
CY2022Q2 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--01-31
CY2022Q2 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2022Q2 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2022Q2 dei Amendment Flag
AmendmentFlag
false
CY2022Q2 dei Entity Registrant Name
EntityRegistrantName
ARGAN INC
CY2022Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q2 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2022Q2 dei Document Period End Date
DocumentPeriodEndDate
2022-04-30
CY2022Q2 dei Document Transition Report
DocumentTransitionReport
false
CY2022Q2 dei Entity File Number
EntityFileNumber
001-31756
CY2022Q2 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2022Q2 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
13-1947195
CY2022Q2 dei Entity Address Address Line1
EntityAddressAddressLine1
One Church Street, Suite 201
CY2022Q2 dei Entity Address City Or Town
EntityAddressCityOrTown
Rockville
CY2022Q2 dei Entity Address State Or Province
EntityAddressStateOrProvince
MD
CY2022Q2 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
20850
CY2022Q2 dei City Area Code
CityAreaCode
301
CY2022Q2 dei Local Phone Number
LocalPhoneNumber
315-0027
CY2022Q2 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022Q2 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022Q2 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2022Q2 dei Entity Small Business
EntitySmallBusiness
false
CY2022Q2 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2022Q2 dei Entity Shell Company
EntityShellCompany
false
CY2022Q2 dei Security12b Title
Security12bTitle
Common Stock, $.15 par value
CY2022Q2 dei Trading Symbol
TradingSymbol
AGX
CY2022Q2 dei Security Exchange Name
SecurityExchangeName
NYSE
CY2022Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
14202731
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
100277000
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
126341000
CY2022Q2 us-gaap Cost Of Revenue
CostOfRevenue
80539000
CY2021Q2 us-gaap Cost Of Revenue
CostOfRevenue
102627000
CY2022Q2 us-gaap Gross Profit
GrossProfit
19738000
CY2021Q2 us-gaap Gross Profit
GrossProfit
23714000
CY2022Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
10575000
CY2021Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
9892000
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
9163000
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
13822000
CY2022Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
595000
CY2021Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
712000
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
9758000
CY2021Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
14534000
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2273000
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3768000
CY2022Q2 us-gaap Profit Loss
ProfitLoss
7485000
CY2021Q2 us-gaap Profit Loss
ProfitLoss
10766000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
7485000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
10766000
CY2022Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-1264000
CY2021Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-118000
CY2022Q2 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
6221000
CY2021Q2 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
10648000
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.50
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.68
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.50
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.67
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14910000
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
15726000
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14992000
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
15961000
CY2022Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.25
CY2021Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.25
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
192255000
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
350472000
CY2022Q2 us-gaap Held To Maturity Securities Current
HeldToMaturitySecuritiesCurrent
175229000
CY2022Q1 us-gaap Held To Maturity Securities Current
HeldToMaturitySecuritiesCurrent
90026000
CY2022Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
36047000
CY2022Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
26978000
CY2022Q2 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
6880000
CY2022Q1 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
4904000
CY2022Q2 us-gaap Other Assets Current
OtherAssetsCurrent
37180000
CY2022Q1 us-gaap Other Assets Current
OtherAssetsCurrent
34904000
CY2022Q2 us-gaap Assets Current
AssetsCurrent
447591000
CY2022Q1 us-gaap Assets Current
AssetsCurrent
507284000
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
9936000
CY2022Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
10460000
CY2022Q2 us-gaap Goodwill
Goodwill
28033000
CY2022Q1 us-gaap Goodwill
Goodwill
28033000
CY2022Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
3175000
CY2022Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
3322000
CY2022Q2 agx Operating Lease Right Of Use Asset Deferred Tax And Other Assets
OperatingLeaseRightOfUseAssetDeferredTaxAndOtherAssets
4075000
CY2022Q1 agx Operating Lease Right Of Use Asset Deferred Tax And Other Assets
OperatingLeaseRightOfUseAssetDeferredTaxAndOtherAssets
4486000
CY2022Q2 us-gaap Assets
Assets
492810000
CY2022Q1 us-gaap Assets
Assets
553585000
CY2022Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
39942000
CY2022Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
41822000
CY2022Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
39365000
CY2022Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
53315000
CY2022Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
106967000
CY2022Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
127890000
CY2022Q2 us-gaap Liabilities Current
LiabilitiesCurrent
186274000
CY2022Q1 us-gaap Liabilities Current
LiabilitiesCurrent
223027000
CY2022Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
4523000
CY2022Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
4963000
CY2022Q2 us-gaap Liabilities
Liabilities
190797000
CY2022Q1 us-gaap Liabilities
Liabilities
227990000
CY2022Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.10
CY2022Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.10
CY2022Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
500000
CY2022Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
500000
CY2022Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.15
CY2022Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.15
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
30000000
CY2022Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
30000000
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
15827772
CY2022Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
15788673
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
14585908
CY2022Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
15257688
CY2022Q2 us-gaap Common Stock Value
CommonStockValue
2374000
CY2022Q1 us-gaap Common Stock Value
CommonStockValue
2368000
CY2022Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
159170000
CY2022Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
158190000
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
192463000
CY2022Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
188690000
CY2022Q2 us-gaap Treasury Stock Shares
TreasuryStockShares
1241864
CY2022Q1 us-gaap Treasury Stock Shares
TreasuryStockShares
530985
CY2022Q2 us-gaap Treasury Stock Value
TreasuryStockValue
47482000
CY2022Q1 us-gaap Treasury Stock Value
TreasuryStockValue
20405000
CY2022Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-3715000
CY2022Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-2451000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
302810000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
326392000
CY2022Q2 us-gaap Minority Interest
MinorityInterest
-797000
CY2022Q1 us-gaap Minority Interest
MinorityInterest
-797000
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
302013000
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
325595000
CY2022Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
492810000
CY2022Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
553585000
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
325595000
CY2022Q2 us-gaap Profit Loss
ProfitLoss
7485000
CY2022Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Before Reclassification And Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax
-1264000
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
920000
CY2022Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
66000
CY2022Q2 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
27077000
CY2022Q2 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
3712000
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
302013000
CY2021Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
322408000
CY2021Q2 us-gaap Profit Loss
ProfitLoss
10766000
CY2021Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Before Reclassification And Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax
-118000
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
679000
CY2021Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1023000
CY2021Q2 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
3942000
CY2021Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
330816000
CY2022Q2 us-gaap Profit Loss
ProfitLoss
7485000
CY2021Q2 us-gaap Profit Loss
ProfitLoss
10766000
CY2022Q2 us-gaap Share Based Compensation
ShareBasedCompensation
920000
CY2021Q2 us-gaap Share Based Compensation
ShareBasedCompensation
679000
CY2022Q2 us-gaap Depreciation
Depreciation
809000
CY2021Q2 us-gaap Depreciation
Depreciation
882000
CY2022Q2 us-gaap Operating Lease Expense
OperatingLeaseExpense
750000
CY2021Q2 us-gaap Operating Lease Expense
OperatingLeaseExpense
776000
CY2022Q2 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
450000
CY2021Q2 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
599000
CY2022Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
166000
CY2021Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
228000
CY2022Q2 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
822000
CY2021Q2 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
114000
CY2022Q2 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
9069000
CY2021Q2 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
3666000
CY2022Q2 us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
1976000
CY2021Q2 us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
-477000
CY2022Q2 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
2291000
CY2021Q2 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-765000
CY2022Q2 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-15229000
CY2021Q2 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-21552000
CY2022Q2 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-20923000
CY2021Q2 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
27506000
CY2022Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-39730000
CY2021Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
17346000
CY2022Q2 us-gaap Payments To Acquire Held To Maturity Securities
PaymentsToAcquireHeldToMaturitySecurities
175000000
CY2021Q2 us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
3520000
CY2022Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-85238000
CY2021Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
15636000
CY2022Q2 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
27077000
CY2022Q2 us-gaap Payments Of Ordinary Dividends
PaymentsOfOrdinaryDividends
3712000
CY2021Q2 us-gaap Payments Of Ordinary Dividends
PaymentsOfOrdinaryDividends
3942000
CY2022Q2 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
66000
CY2021Q2 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1023000
CY2022Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-30723000
CY2021Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-2919000
CY2022Q2 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-2526000
CY2021Q2 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-59000
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-158217000
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
30004000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
350472000
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
366671000
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
192255000
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
396675000
CY2022Q2 agx Retained Amount Under Construction Contracts
RetainedAmountUnderConstructionContracts
41800000
CY2022Q1 agx Retained Amount Under Construction Contracts
RetainedAmountUnderConstructionContracts
40400000
CY2022Q2 agx N Priced Change Orders Included In Transaction Prices
NPricedChangeOrdersIncludedInTransactionPrices
6800000
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
100277000
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
126341000
CY2022Q1 us-gaap Capitalized Contract Cost Impairment Loss
CapitalizedContractCostImpairmentLoss
7900000
CY2022Q1 agx N Priced Change Orders Included In Transaction Prices
NPricedChangeOrdersIncludedInTransactionPrices
7500000
CY2022Q2 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
339200000
CY2022Q2 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P3Y
CY2022Q2 us-gaap Revenue Remaining Performance Obligation Percentage
RevenueRemainingPerformanceObligationPercentage
0.74
CY2022Q2 us-gaap Allowance For Notes And Loans Receivable Current
AllowanceForNotesAndLoansReceivableCurrent
2400000
CY2022Q1 us-gaap Allowance For Notes And Loans Receivable Current
AllowanceForNotesAndLoansReceivableCurrent
2400000
CY2022Q2 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
7426000
CY2022Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
4252000
CY2022Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
3322000
CY2022Q2 agx Amount Outstanding Letter Of Credit Issued By Bank In Support Of Project Development Activities And Deposited In Bank As Collateral
AmountOutstandingLetterOfCreditIssuedByBankInSupportOfProjectDevelopmentActivitiesAndDepositedInBankAsCollateral
3400000
CY2022Q1 agx Amount Outstanding Letter Of Credit Issued By Bank In Support Of Project Development Activities And Deposited In Bank As Collateral
AmountOutstandingLetterOfCreditIssuedByBankInSupportOfProjectDevelopmentActivitiesAndDepositedInBankAsCollateral
3400000
CY2021Q2 us-gaap Operating Lease Expense
OperatingLeaseExpense
800000
CY2022Q2 us-gaap Operating Lease Expense
OperatingLeaseExpense
800000
CY2021Q2 us-gaap Operating Lease Payments
OperatingLeasePayments
800000
CY2022Q2 us-gaap Operating Lease Payments
OperatingLeasePayments
800000
CY2022Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P44M
CY2022Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.024
CY2022Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
200000
CY2021Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
500000
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
958000
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
456000
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
351000
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
250000
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
231000
CY2022Q2 agx Lessee Operating Lease Liability To Be Paid After Year Four
LesseeOperatingLeaseLiabilityToBePaidAfterYearFour
1025000
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
3271000
CY2022Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
190000
CY2022Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
3081000
CY2022Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1031000
CY2022Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2050000
CY2022Q2 agx Remaining Bonded Performance Obligations
RemainingBondedPerformanceObligations
187000000.0
CY2022Q2 agx Bonds Outstanding Covering Other Risks
BondsOutstandingCoveringOtherRisks
1100000
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1405000
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
44.35
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y2M1D
CY2022Q1 agx Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Stock Option Outstanding Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsStockOptionOutstandingWeightedAverageGrantDateFairValue
10.31
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
38000
CY2022Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
36.78
CY2022Q2 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
2000
CY2022Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
32.68
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
3000
CY2022Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
63.76
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1438000
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
44.12
CY2022Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y14D
CY2022Q2 agx Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Stock Option Outstanding Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsStockOptionOutstandingWeightedAverageGrantDateFairValue
10.21
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1199000
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
44.87
CY2022Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P5Y6M7D
CY2022Q2 agx Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Stock Option Exercisable Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsStockOptionExercisableWeightedAverageGrantDateFairValue
10.76
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1408000
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
44.50
CY2021Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y9M7D
CY2021Q2 agx Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Stock Option Outstanding Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsStockOptionOutstandingWeightedAverageGrantDateFairValue
10.44
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1029000
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
45.47
CY2021Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P6Y3D
CY2021Q2 agx Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Stock Option Exercisable Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsStockOptionExercisableWeightedAverageGrantDateFairValue
11.24
CY2022Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
295000
CY2022Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
7.80
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
38000
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
6.68
CY2022Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
94000
CY2022Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
8.24
CY2022Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
239000
CY2022Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
7.45
CY2021Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
379000
CY2021Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
8.25
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
2000000.0
CY2022Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
1900000
CY2022Q2 us-gaap Share Based Compensation
ShareBasedCompensation
900000
CY2021Q2 us-gaap Share Based Compensation
ShareBasedCompensation
700000
CY2022Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
8400000
CY2022Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P3Y
CY2022Q2 agx Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Period For Monthly Closing Prices
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRatePeriodForMonthlyClosingPrices
P5Y
CY2022Q2 agx Percentage Reduction In Aggregate Fair Value Of Stock Option
PercentageReductionInAggregateFairValueOfStockOption
0.885
CY2022Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Purchase Price Of Common Stock Percent
SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent
0.50
CY2021Q2 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2022Q2 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2022Q2 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
2049000
CY2021Q2 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
3052000
CY2022Q2 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
134000
CY2021Q2 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
334000
CY2022Q2 agx Effective Income Tax Rate Reconciliation Stock Award Valuation Allowances
EffectiveIncomeTaxRateReconciliationStockAwardValuationAllowances
66000
CY2021Q2 agx Effective Income Tax Rate Reconciliation Stock Award Valuation Allowances
EffectiveIncomeTaxRateReconciliationStockAwardValuationAllowances
284000
CY2022Q2 us-gaap Income Tax Reconciliation Nondeductible Expense Other
IncomeTaxReconciliationNondeductibleExpenseOther
24000
CY2021Q2 us-gaap Income Tax Reconciliation Nondeductible Expense Other
IncomeTaxReconciliationNondeductibleExpenseOther
98000
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2273000
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3768000
CY2022Q2 agx Increase In Loss Carryback Period For Certain Losses
IncreaseInLossCarrybackPeriodForCertainLosses
P5Y
CY2020Q1 agx Domestic Net Operating Loss Carryback
DomesticNetOperatingLossCarryback
39500000
CY2022Q2 us-gaap Income Tax Receivable
IncomeTaxReceivable
12700000
CY2019 agx Period For Identify And Quantify Research And Development Tax Credits
PeriodForIdentifyAndQuantifyResearchAndDevelopmentTaxCredits
P3Y
CY2020Q1 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
16600000
CY2021Q1 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
400000
CY2022Q2 agx Unrecognized Income Tax Benefits Related To Research And Development Credits
UnrecognizedIncomeTaxBenefitsRelatedToResearchAndDevelopmentCredits
5000000.0
CY2022Q1 agx Unrecognized Income Tax Benefits Related To Research And Development Credits
UnrecognizedIncomeTaxBenefitsRelatedToResearchAndDevelopmentCredits
5000000.0
CY2022Q2 agx Income Tax Refunds And Prepaid Income Taxes
IncomeTaxRefundsAndPrepaidIncomeTaxes
27700000
CY2022Q1 agx Income Tax Refunds And Prepaid Income Taxes
IncomeTaxRefundsAndPrepaidIncomeTaxes
29500000
CY2022Q2 us-gaap Equity Method Investments
EquityMethodInvestments
800000
CY2022Q1 us-gaap Equity Method Investments
EquityMethodInvestments
200000
CY2022Q2 agx Investments Term
InvestmentsTerm
P6Y
CY2021Q2 us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
3500000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
7485000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
10766000
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14910000
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
15726000
CY2022Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
82000
CY2021Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
235000
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14992000
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
15961000
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.50
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.68
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.50
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.67
CY2022Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
867334
CY2021Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
279500
CY2022Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.25
CY2021Q2 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.25
CY2022Q2 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
710879
CY2022Q2 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
27100000
CY2022Q2 us-gaap Share Price
SharePrice
38.09
CY2022Q2 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
100277000
CY2022Q2 us-gaap Cost Of Revenue
CostOfRevenue
80539000
CY2022Q2 us-gaap Gross Profit
GrossProfit
19738000
CY2022Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
10575000
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
9163000
CY2022Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
595000
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
9758000
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2273000
CY2022Q2 us-gaap Profit Loss
ProfitLoss
7485000
CY2022Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
166000
CY2022Q2 us-gaap Depreciation
Depreciation
809000
CY2022Q2 us-gaap Property Plant And Equipment Additions
PropertyPlantAndEquipmentAdditions
238000
CY2022Q2 us-gaap Assets Current
AssetsCurrent
447591000
CY2022Q2 us-gaap Liabilities Current
LiabilitiesCurrent
186274000
CY2022Q2 us-gaap Goodwill
Goodwill
28033000
CY2022Q2 us-gaap Assets
Assets
492810000
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
126341000
CY2021Q2 us-gaap Cost Of Revenue
CostOfRevenue
102627000
CY2021Q2 us-gaap Gross Profit
GrossProfit
23714000
CY2021Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
9892000
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
13822000
CY2021Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
712000
CY2021Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
14534000
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3768000
CY2021Q2 us-gaap Profit Loss
ProfitLoss
10766000
CY2021Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
228000
CY2021Q2 us-gaap Depreciation
Depreciation
882000
CY2021Q2 us-gaap Property Plant And Equipment Additions
PropertyPlantAndEquipmentAdditions
844000
CY2021Q2 us-gaap Assets Current
AssetsCurrent
559031000
CY2021Q2 us-gaap Liabilities Current
LiabilitiesCurrent
283065000
CY2021Q2 us-gaap Goodwill
Goodwill
27943000
CY2021Q2 us-gaap Assets
Assets
617972000

Files In Submission

Name View Source Status
0001558370-22-009830-index-headers.html Edgar Link pending
0001558370-22-009830-index.html Edgar Link pending
0001558370-22-009830.txt Edgar Link pending
0001558370-22-009830-xbrl.zip Edgar Link pending
agx-20220430.xsd Edgar Link pending
agx-20220430x10q.htm Edgar Link pending
agx-20220430x10q001.jpg Edgar Link pending
agx-20220430x10q_htm.xml Edgar Link completed
agx-20220430xex31d1.htm Edgar Link pending
agx-20220430xex31d2.htm Edgar Link pending
agx-20220430xex32d1.htm Edgar Link pending
agx-20220430xex32d2.htm Edgar Link pending
agx-20220430_cal.xml Edgar Link unprocessable
agx-20220430_def.xml Edgar Link unprocessable
agx-20220430_lab.xml Edgar Link unprocessable
agx-20220430_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending